Cronus Pharma unveils FDA-approved generic Robenacoxib injection for veterinary use
Bausch + Lomb advances two first-in-class eye treatments to new trials
Abbott wins FDA authorization for first dual glucose-ketone sensor
Piramal Pharma reports 22.6% reduction in Scope 1 and Scope 2 greenhouse gas emissions
Jagat Pharma expands nutraceutical portfolio with six new wellness products
Zepbound use linked to lower healthcare costs in older adults: Lilly study
COSCON 2026 to bring together 1,250+ aesthetic medicine experts in New Delhi
Nippon Soda hits milestone in MabGenesis deal for feline inflammatory disease treatment
Thermo Fisher launches Orbitrap Mass Spectrometers
Aragen Life Sciences files DRHP with SEBI for Rs. 800 crore fresh issue IPO
The company currently holds 96% of Bharat Serums and Vaccines directly, while the remaining 4% is held through its wholly owned subsidiary, Appian Properties
Subscribe To Our Newsletter & Stay Updated
Chasing Consistency: Centralizing operations data is the key to optimizing chemicals plants
Implementing a digital transformation in chemical operations to maximize profitability
The complexity of compliance
The Sprint to the Summit: Unlocking Lab Efficiency through Digital Transformation
The guiding role of fluidized and spouted bed technologies in particle building processes